WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009118187) METHODS FOR TREATING DISORDERS USING NMDA NR2B-SUBTYPE SELECTIVE ANTAGONIST
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/118187    International Application No.:    PCT/EP2009/002241
Publication Date: 01.10.2009 International Filing Date: 26.03.2009
IPC:
A61K 31/505 (2006.01), C07D 403/06 (2006.01), A61P 25/28 (2006.01), A61P 25/16 (2006.01)
Applicants: EVOTEC NEUROSCIENCES GMBH [DE/DE]; Schnackenburgallee 114, 22525 Hamburg (DE) (For All Designated States Except US).
KEMP, John, Alan [GB/CH]; (CH) (For US Only).
TASKER, Timothy [GB/GB]; (GB) (For US Only)
Inventors: KEMP, John, Alan; (CH).
TASKER, Timothy; (GB)
Agent: RUPP, Christian; Mitscherlich & Partner Postfach 33 06 09 80066 München (DE)
Priority Data:
61/040,087 27.03.2008 US
Title (EN) METHODS FOR TREATING DISORDERS USING NMDA NR2B-SUBTYPE SELECTIVE ANTAGONIST
(FR) PROCÉDÉS POUR TRAITER DES TROUBLES UTILISANT UN ANTAGONISTE SÉLECTIF DE SOUS-TYPE NR2B DE NMDA
Abstract: front page image
(EN)A method of treating, preventing or ameliorating a disease or condition by inhibiting NR2B subunit containing NMDA receptors using a compound according to formula (I) or a pharmaceutically acceptable salt thereof:
(FR)La présente invention concerne un procédé de traitement, prévention ou amélioration d’une maladie ou pathologie par inhibition de récepteurs NMDA contenant la sous-unité NR2B utilisant un composé selon la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci :
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)